Saula Checquolo

Pubblicazioni

Titolo Pubblicato in Anno
Opsonin-deficient nucleoproteic corona Endows unPEGylated liposomes with stealth properties in vivo ACS NANO 2022
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential JOURNAL OF HEPATOLOGY 2022
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance FRONTIERS IN ONCOLOGY 2022
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL CANCERS 2022
Notch signaling in female cancers. A multifaceted node to overcome drug resistance CANCER DRUG RESISTANCE 2021
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response ONCOGENESIS 2020
Current trends in ATRA delivery for cancer therapy PHARMACEUTICS 2020
Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation INTERNATIONAL JOURNAL OF ONCOLOGY 2019
Notch3 targeting. A novel weapon against ovarian cancer stem cells STEM CELLS INTERNATIONAL 2019
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL FRONTIERS IN ONCOLOGY 2019
Notch signaling activation as a hallmark for triple-negative breast cancer subtype JOURNAL OF ONCOLOGY 2019
Wnt, notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer FRONTIERS IN GENETICS 2019
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance CANCER RESEARCH 2019
Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment PATHOBIOLOGY: FROM MOLECULAR DISEASE TO CLINICAL APPLICATION 2019
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application The XI Notch meeting 2019
Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer NEW TECHNOLOGIES TO FIGHT CANCER 2019
PLK1 targets NOTCH1 during DNA damage and mitotic progression THE JOURNAL OF BIOLOGICAL CHEMISTRY 2019
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response The Biennial Congress of the Italian Association of cell biology and differentiation 2019
Notch signaling as a therapeutic target for acute lymphoblastic leukemia EXPERT OPINION ON THERAPEUTIC TARGETS 2018
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. Atti del ABCD - PPh.D. meeting 2018

Interessi di ricerca

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma